{"slideshow_credits": null, "snippet": "GlaxoSmithKline will plead guilty to promoting two drugs for unapproved uses and to failing to report important safety data about a diabetes drug.", "abstract": "British drugmaker GlaxoSmithKline agrees to plead guilty to criminal charges and pay $3 billion in fines for promoting its best-selling antidepressants for unapproved uses and failing to report safety data about a top diabetes drug; the fine against GlaxoSmithKline over Paxil, Wellbutril, Avandia and other drugs makes this year a record for money recovered by the federal government under its so-called whistle-blower law.", "section_name": "Business Day", "print_page": "1", "document_type": "article", "byline": {"person": [{"firstname": "Katie", "role": "reported", "lastname": "THOMAS", "rank": 1, "organization": ""}, {"lastname": "SCHMIDT", "rank": 2, "firstname": "Michael", "role": "reported", "organization": "", "middlename": "S."}], "original": "By KATIE THOMAS and MICHAEL S. SCHMIDT", "contributor": ""}, "web_url": "http://www.nytimes.com/2012/07/03/business/glaxosmithkline-agrees-to-pay-3-billion-in-fraud-settlement.html", "lead_paragraph": "GlaxoSmithKline will plead guilty to promoting two drugs for unapproved uses and to failing to report important safety data about a diabetes drug.", "headline": {"seo": "GlaxoSmithKline Agrees to Pay $3 Billion in Fraud Settlement", "main": "Glaxo Agrees to Pay $3 Billion in Fraud Settlement", "print_headline": "Drug Firm Guilty In Criminal Case"}, "_id": "53f86dfa38f0d835538dcb00", "word_count": "1048", "multimedia": [{"height": 126, "url": "images/2012/07/03/business/Drug/Drug-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2012/07/03/business/Drug/Drug-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 400, "url": "images/2012/07/03/business/Drug/Drug-articleLarge.jpg", "legacy": {"xlarge": "images/2012/07/03/business/Drug/Drug-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "400"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2012/07/03/business/Drug/Drug-thumbStandard.jpg", "legacy": {"thumbnail": "images/2012/07/03/business/Drug/Drug-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2012-07-03T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "N", "rank": "1"}, {"value": "GlaxoSmithKline PLC", "name": "organizations", "is_major": "Y", "rank": "2"}, {"value": "Food and Drug Administration", "name": "organizations", "is_major": "N", "rank": "3"}, {"value": "Whistle-Blowers", "name": "subject", "is_major": "Y", "rank": "4"}, {"value": "Fines (Penalties)", "name": "subject", "is_major": "N", "rank": "5"}, {"value": "Antidepressants", "name": "subject", "is_major": "N", "rank": "6"}, {"value": "Frauds and Swindling", "name": "subject", "is_major": "N", "rank": "7"}, {"value": "Paxil (Drug)", "name": "subject", "is_major": "Y", "rank": "8"}, {"value": "Avandia (Drug)", "name": "subject", "is_major": "Y", "rank": "9"}, {"value": "Wellbutrin (Drug)", "name": "subject", "is_major": "Y", "rank": "10"}], "blog": [], "subsection_name": null, "type_of_material": "News"}